Given the paucity of data and the heterogeneous and conflicting results of prior investigations, we sought to determine the expression patterns and prognostic value of mesothelin in advanced lung adenocarcinoma and the association of mesothelin expression with other molecular alterations and clinico-pathologic variables. Here, MSLN is linked to lung adenocarcinoma.